Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$542.50 -6.54 (-1.19%)
At close: Nov 5, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Raw Materials (2011 - 2012)

Updated

Vertex Pharmaceuticals' Raw Materials came in at $4.51 million for Q3 2012, down 77.6% from $20.1 million a year earlier and down 11.2% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Raw Materials (2011 - 2012) Analysis & Trends

At the end of FY2011, Vertex Pharmaceuticals' Raw Materials was $32.21 million.

  • Business Quant data shows VRTX's Raw Materials at $5.08 million (Q2 2012), $28.51 million (Q1 2012) and $32.21 million (Q4 2011) in the three quarters before Q3 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn
5 Novartis Ag 313.89 Bn 287.12 Bn -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn
10 Vertex Pharmaceuticals 137.20 Bn 109.19 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 4.51 Mn
Jun 30, 2012 5.08 Mn
Mar 31, 2012 28.51 Mn
Dec 31, 2011 32.21 Mn
Sep 30, 2011 20.10 Mn
Jun 30, 2011 21.77 Mn
Mar 31, 2011 7.82 Mn
API Access

Vertex Pharmaceuticals Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=VRTX&period=max&api_key=YOUR_API_KEY